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Abstract
There are multiple factors that influence surgical treatment decision making at the time of 
diagnosis for women with breast cancer. The purpose of this study is to identify these factors that 
may be related to the surgical choice made in the treatment of breast cancer by women. Gaps in 
the existing research literature revealed a lack of prospective (pre-surgical) studies. The proposed 
study addresses this gap by focusing on pre-surgical decision making regarding the various 
factors that impact why women choose mastectomy when the stage of and type of their cancer 
allows breast conserving surgery as an option. This prospective, mixed mode design was 
conducted in a mid-Michigan oncology private practice setting. The purposive sample included 
a total of 10 participants, 3 scheduled for modified radical mastectomy (MRM) surgery and the 
other 7 scheduled for breast conserving surgery (BCS). A Factor List developed by Ward and 
colleagues (1989) was adapted to use in content analysis of narrative data from an open-ended 
question for participants’ thoughts and feelings about their surgical treatment decisions. Results 
revealed most participants were <60 years of age, Caucasian, married, employed, and had full 
coverage health insurance. The following content analysis findings were consistent with 
previous post-op findings. Among the 10 participants, 90% stated that their physician’s opinion 
was an impact in surgical treatment choice. Fear of side effects from chemo and radiation, length 
of recovery, and fear of recurrence were also discovered as influences regarding type of surgical 
treatment chosen. In addition, 10 new factors/themes emerged including fear (nonspecified) 
(60%), involved support system (60%), information given (40%), personal decision (30%) and 
strong faith/spirituality beliefs (30%). Other factors/themes (10-20%) were previous experience 
with someone with breast cancer, guidance from the nurse navigator, trust (nonspecified), age,
and fear of subsequent surgeries. Fisher’s Exact test revealed no significant relationship between
type of surgery (MRM, BCS) and actual breast satisfaction ratings by participants. There was no 
significant relationship between demographic variables and breast satisfaction. Findings are 
beneficial to nurse practitioners and other health care providers who can enhance their 
understanding about the experience women go through during this difficult time, and may 
ultimately facilitate the surgical treatment decision making process for patients with breast 
cancer.
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Chapter I 
Introduction
Breast cancer is a disease that affects thousands of women every year. According to the 
National Cancer Institute (2007), there have already been an estimated 178,480 new cases and 
40,460 deaths in women from breast cancer in 2007. The American Cancer Society has 
documented 6,880 new cases of breast cancer in Michigan alone for 2007. When diagnosed with 
breast cancer, women are not only facing a life altering disease, but also a physical and 
emotional surgical decision. Healthcare providers need to be aware that the diagnosis of breast 
cancer immediately changes a woman’s life (Boehmke & Dickerson, 2006). Surgical 
intervention continues to be the primary treatment for these women. The surgical options 
available to women are modified radical mastectomy (MRM) with or without immediate 
reconstruction, breast conserving surgery (BCS) or lumpectomy, and prophylactic mastectomy.
BCS, also known as a lumpectomy, is the surgical removal of the breast lump or tumor, 
not the entire breast. MRM is the removal of the entire breast and nipple, some skin, and some 
underarm lymph nodes. Following BCS surgery, women will need additional treatment with 
radiation therapy. After MRM, radiation treatment is not common (Yarbro, Frogge, Goodman, & 
Groenwald, 2000). Women diagnosed with breast cancer have several decisions to make and an 
abundance of information to absorb regarding treatment possibilities. In the State of Michigan, it 
is required by law that all women receive a booklet entitled, “Breast Cancer: What You Need to 
Know Before Treatment” (Michigan Department of Community Health, 2003). The purpose of 
this booklet is to inform women about treatment options for breast cancer.
Clinical trials have demonstrated that the survival rates between women receiving 
modified radical mastectomy or breast conserving surgery combined with radiation therapy have
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no significant difference in disease outcome (Reaby, 1998). Eight-year studies conducted by 
Fisher et al. (1989) illustrate the equivalence of the survival rates of mastectomy and breast 
conserving surgery with radiation among women with early stage breast cancer. Despite this 
well-known research, many women continue to choose modified radical mastectomy as opposed 
to breast conserving surgery. Numerous factors may impact the woman during this decision 
making process. Possible factors that may influence the surgical treatment decision for women 
with breast cancer include: previous knowledge of cancer, reaction to diagnosis, perceived 
urgency of treatment, support people, information provided, demographics, and body image 
(Halkett, Arbon, Scutter, & Borg, 2005). Other plausible factors that may influence a women’s 
treatment decision include family history, presence of BRCA 1 and BRCA 2 genes, fear, breast 
satisfaction, and demographic components.
Throughout the review of literature, the majority of the studies conducted were 
retrospective. Ward et al. (1989) makes note that retrospective report bias is a concern with these 
types of studies because the researchers cannot be certain that the patients would have responded 
in the same way if they were interviewed prior to surgery. Ananian et al. (2004) similarly state 
that there have been no prospective studies conducted to assess the importance of women’s body 
image when patients have to make their choice of surgical treatment. Harcourt and Rumsey 
(2001) suggest that gaps in the existing research literature such as the majority of retrospective 
studies need to be addressed. Harcourt and Rumsey state that research must be prospective and 
multi-centered to fill these gaps. These implications for future research have justified the need 
and development of this research question, “What factors influence the surgical treatment 
decision-making at the time of diagnosis for women with breast cancer?”
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Chapter II 
Literature Review
Theoretical Framework
Polit and Beck (2004) describe the first step of developing a theory as the process of 
formulating relevant concepts and creating a conceptual analysis. According to Higgins and 
Moore (2000), “the terms theory, theoretical (or conceptual model), theoretical framework, and 
theoretical system... can be used interchangeably” (p. 179). However, the level of theoretical 
thinking must be defined. This study is theory-generating. It is a prospective study which means 
data are collected before surgical intervention. This prospective design will allow a greater 
understanding about the decision making for women soon after their diagnosis with breast cancer 
by formulating relevant concepts.
Ward, Heidrich, & Wolberg (1989) conducted a retrospective study of 22 women using 
the “Factor List” (Appendix A). This list was composed of 16 fixed response questions using a 
Likert scale. Eleven of these women chose breast conserving surgery, and the eleven other 
women chose modified radical mastectomy. These researchers found that women chose breast 
conserving surgery because they desired to maintain their body integrity. They also found a trend 
in those choosing breast conserving surgery to be more concerned about their partner’s feelings 
regarding breast removal. Other findings revealed that involvement in decision-making was 
important to the participants.
An Australian research team also used the Factor List (Ward, Heidrich & Wolberg, 1989) 
in their study, “Factors influencing women’s decisions for choice of surgery for Stage I and 
Stage II breast cancer in Western Australia” (Mastaglia & Kristjanson, 2001). This study
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followed a retrospective design. The researchers found fear of recurring cancer, fear of dying, 
and avoiding future surgeries were all factors that influenced treatment decision making among 
women who chose MRM. Women who chose BCS identified physician preference, fear of 
recurrence and dying as influential factors in their treatment decision. Both research teams 
contributed knowledge post surgery that was useful to the investigators in designing their 
prospective study especially related to guiding the literature review.
Throughout the review of literature, recurrent factors were identified by women who had 
surgical treatment for breast cancer. Body image and self concept, demographic factors, family 
history and genetic composition, fear, and preferred role in the decision making process were 
among the most frequent occurring themes in past retrospective studies.
Body Image and Self-Concept
Cancer of the breast is unique. Not only does this disease cause pain, suffering, and the 
possibility of death, but it also imposes a potential threat to a woman’s perceptions of 
herself through an attack on her body that is endowed with the symbolic significance of 
femininity and womanliness (cited in Reaby, 1998, p. 252).
The term body image can overlap with other aspects such as self-esteem, self-concept, 
confidence level, and sexuality. Hopwood (1993) acknowledges that this can make the 
assessment of body image very complicated. There is not a universal instrument that measures 
body image. Therefore, researchers often develop their own assessment tools which can cause 
difficulties when comparing studies (Harcourt & Rumsey, 2001). Several studies suggest there is 
a strong correlation between body image and the breast cancer surgical intervention (Mock,
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1993; Al-Ghazal, Sully, Fallowfield, & Blarney, 2000; Ward et al., 1989; Halkett et al., 2005; 
Margolis, Goodman, & Rubin, 1990). Body image also impacts the choice of breast 
reconstructive surgery following mastectomy (Ananian et al., 2004; Harcourt & Rumsey).
Several retrospective study designs revealed interesting results. Al-Ghazal and colleagues 
(2000) performed a retrospective study using a body image scale specifically designed for 
women who had surgery for breast cancer. Results of this European study showed women who 
had immediate reconstruction had higher body image scores than women who delayed their 
reconstructive surgeries. Al-Ghazal made no comparison with women who had mastectomy 
alone without reconstruction. In another study, Lasry et al. (1987) studied body image 
satisfaction three years postmastectomy and breast conserving surgery in a randomized clinical 
trial. Body image was measured using a tool designed by the researchers entitled, the “Body 
Image Index.” Results showed women with mastectomy had lower levels of body image 
satisfaction than women with breast conserving surgery (p < .001). In an interesting study 
conducted by Ward, Heidrich, & Wolberg (1989) with 22 women, eleven of these women chose 
breast conserving surgery, and the eleven other women chose modified radical mastectomy.
Ward found that women chose breast conserving surgery because they desired to maintain their 
body integrity. Ward also found a trend in those choosing breast conserving surgery to be more 
concerned about their partner’s feelings about breast removal. A limitation of this study was the 
small sample size and the homogenous sample purposely obtained from one clinical setting. A 
retrospective postal survey using a larger sample size of 257 women (Mock, 1993) found women 
who underwent breast conserving surgery had higher body image scores as compared to the 
mastectomy group (p < .001). The mastectomy group was made up of some women who had 
reconstruction and others who did not. This study also found that these women were still
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adapting to their body image one year following surgery, which led the author to recognize the 
need for longitudinal prospective research in this area (Mock).
A prospective, cross-sectional French study (Ananian et al., 2004) determined factors that 
affect women’s choice to undergo reconstruction with mastectomy. Self-administered 
questionnaires were given to the women prior to surgery. Those who opted for breast 
reconstruction frequently realized that their body image was important to them (p < .01).
A qualitative study (Margolis et al., 1990) focused on the psychological aspects of breast 
conserving surgery. Researchers found women choosing breast conserving surgery did so based 
on concerns of negative impact to their body image and sexuality. A limitation of this study was 
the sample containing women choosing breast conserving surgery only. Women choosing 
mastectomy were not included.
Kraus’ 1999 study illustrated results that are in contrast to the findings of the literature 
reviewed by the investigators for their study. Kraus examined body image, decision-making, and 
breast cancer treatment using a prospective design to compare 31 women with breast cancer 
undergoing surgical intervention to 30 women without breast cancer. The women with breast 
cancer experienced a decrease in body image scores postoperatively. However, contrary to 
previous research, “there was a trend in the data for the mastectomy group to be more satisfied 
with their body image than the breast conserving surgery group before and after treatment” (p. 
425). One explanation Kraus gave for these findings suggested that for women faced with a life 
threatening illness such as breast cancer, physical importance is second to survival. This 
explanation is supported by a cited work in Beaver et al stating, “.. .decision-making ability is 
limited as a result of the life-threatening nature of the condition” (Parry, G. as cited in Kraus,
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1999, p. 17). A second possibility for these findings may be some women used denial as a 
defense mechanism against negative body image. A longitudinal study with a larger sample size 
is necessary to refute the previous research and support Kraus’s results.
Demographic Factors
Previous research, although not solely focusing on one demographic variable, has 
identified links between numerous factors and breast cancer surgical treatment choice. These 
variables include age, socioeconomic status, education, and marital status. Women choosing 
reconstruction, for example, were found to be younger, highly educated, of higher 
socioeconomic status, and more likely to be in a relationship (Ananian et al., 2004; Harcourt & 
Rumsey, 2001). Age was also recurrent factor that correlated with the type of surgical 
intervention women chose. Younger women tended to choose breast-conserving surgery, 
whereas older women choose modified radical mastectomy (Ananian et al.). An epidemiological 
surveillance showed that women greater than 85 years old and younger than 55 years had higher 
rates for breast conserving surgery (Samet, Hunt, & Farrow, 1994). A retrospective study by 
Ward, Heidrich, and Wolberg (1989) found the mean age for women who chose breast- 
conserving surgery was 50. This was significantly younger than the mean age of the women 
choosing modified radical mastectomy, at 59.5 years (SD = 8.9 years). When making a decision 
for breast cancer surgery, older women may consider their life expectancy, the efficacy of 
treatment, toxicity, and possible effects on their quality of life in differently than younger women 
(Kutner, Vu, Prindville, & Byers, 2000).
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Family History/Genetic Composition
A breast cancer (BRCA) gene test is a blood test to check for specific mutations in genes 
that help control normal cell growth. Breast cancer susceptibility has been linked to mutations 
within these genes. BRCA 1, located on chromosome 17q, is believed to account for 30-45% of 
breast cancer cases in families with a high incidence of early onset of both breast and ovarian 
cancers. BRCA2, located on chromosome 13q, is also believed to account for approximately 
35% of families with early breast cancer. Researchers are continuing to explore further genes 
that may also be responsible for increasing one’s susceptibility to breast cancer. Since 
approximately less than 1% of the population has this mutation the implications and testing 
remains complicated. Any changes in the BRCA1 and BRCA2 genes assist providers to 
determine a woman’s chance of developing breast and ovarian cancer (Yarbro, Frogge, 
Goodman, & Groenwald, 2000).
There are other risk factors for breast cancer. These include age >50, postmenopausal 
obesity, early menarche with late menopause, first pregnancy after age 30, use of oral 
contraceptives before age 20 and lasting greater than 6 years, benign breast disease, diet, alcohol, 
and hormone replacement therapy (Yarbro et al., 2000). If women have any of these risk factors 
for breast cancer, they may also opt to have genetic testing for the BRCA genes. If a woman is 
known to carry the mutation, she can use this information to assist with decision making. It is 
often these women who are considered high risk and are positive for BRCA gene mutations who 
choose prophylactic mastectomy. A study done by Hartmann, Schaid, & Woods et al., (1999) 
found a greater than 90% reduction in risk of breast cancer in women who had a family history 
of breast cancer and were high risk who underwent prophylactic mastectomy.
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In the study by Ananian et al. (2004), the sample of women who chose mastectomy had a 
first degree relative with a history of breast cancer. A prospective study by Hatcher, Fallowfield, 
& A’Hem (2001) found that women who underwent prophylactic mastectomy did so due to their 
belief that it would greatly decrease their risk of developing breast cancer. Hatcher and 
colleagues state in the discussion that women who choose prophylactic mastectomy often have 
inaccurate perceptions of their actual risk of disease. Therefore, Hatcher emphasizes that women 
need to meet with genetic counselors to ensure that their surgical decisions are based on accurate 
perceptions.
Fear
Fear is a concept several researchers correlated with women’s surgical decisions in their 
studies related to breast cancer (Ananian et al., 2004; Kraus, 1999; Mastaglia & Kristjanson,
2001; Ward et al., 1989). Ananian and colleagues state that fear of surgery was an important 
concern for women choosing mastectomy. This fear of surgery prevented the women from opting 
for reconstruction either before or after their mastectomy. Kraus found that fear of recurrence 
and radiation therapy were common factors among the women who chose to have a mastectomy. 
In Mastalgia and Krisjanson’s retrospective study, women stated fear of cancer recurrence, fear 
of further surgery, and fear of dying from cancer were factors for choosing mastectomy. Women 
who chose breast conserving surgery also stated fear of recurrence and dying from cancer were 
factors that led them to their decision. Ward et al. also identified three most important factors for 
the surgical decision among all participants in the study. One factor was fear of recurrence and 
the other two factors of equal importance were avoiding a second surgery and physician’s
Breast Cancer and Decision Making 10
preference. Furthermore, Ward found the breast conserving group identified fear of losing a 
breast as an important factor for their surgical decision.
Preferred Role in the Decision Making Process
A common variable recognized in the review of literature is the women’s role in the 
decision making process. There are varying degrees in which a woman desires to participate in 
the surgical decision following a diagnosis of breast cancer (Beaver, Luker, Owens, Leinster, & 
Degner, 1996; Halkett et al., 2005; Harcourt & Rumsey, 2001; Mastalgia & Kristjanson, 2001; 
Reaby, 1998). A British study conducted by Beaver et al., stated that women diagnosed with 
breast cancer are being encouraged more frequently to be involved in the decision regarding their 
treatment. Beaver et al further state that the extent to which women feel comfortable with 
surgical decision making needs to be determined. The results from Beaver and colleagues show 
that women diagnosed with breast cancer prefer to have the physician make the final treatment 
decision. One explanation may be that breast cancer, as a life threatening illness, may limit the 
women’s decision-making ability (cited in Beaver et al; Kraus, 1999). Researchers with similar 
findings agree that women may find the choice of treatment stressful due to the news of the 
breast cancer diagnosis impairing their ability to think clearly (Pierce, 1993; Fallowfield, Hall, 
Maguire, Baum, & A’Hem, 1994).
Possible influences impacting the participation in the decision-making process include 
the presence of support people, the reaction to the breast cancer diagnosis, and the physician’s 
opinion (Halkett et al., 2005). Halkett and colleagues also found that the physician involved in a 
woman’s treatment decision may have personal beliefs that will impact the woman’s final 
choice. Ward et al. (1989) found that women who perceived themselves as an active participant
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in the decision making process had a positive adjustment to their breast surgery treatment choice. 
In a retrospective study, Mastalgia and Kristjanson (2001) found that women who underwent 
breast-conserving surgery stated that the physician’s preference impacted their final decision for 
surgical option, whereas women who underwent modified radical mastectomy stated the 
physicians’ preference was not a factor.
Conclusion
The literature review identifies several factors that influence the surgical treatment choice 
among women with breast cancer. The review supports body image, family history, 
demographics, fear, and preferred role in the decision making process as important points to 
consider when women are faced with the breast cancer diagnosis. However, the majority of the 
studies conducted were retrospective. Ward et al. (1989) makes note that retrospective bias is a 
concern with these types of studies, and is uncertain that the responses would have been similar 
if the participants were seen prior to their surgery. Ananian et al. (2004) similarly stated that 
there have been no reliable prospective surveys to assess body image importance prior to 
surgery. Harcourt and Rumsey (2001) suggest that gaps in the existing research literature such as 
the majority of retrospective studies, need to be addressed. “Research in this field needs to be 
prospective and multicentered” (Harcourt & Rumsey, p. 485). These implications for future 
research have justified the need and development of this research question, “What factors 
influence surgical treatment decision-making at the time of diagnosis for women with breast 
cancer?”
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Chapter III 
Methodology
Research Design
This study follows a prospective mixed mode design which includes a blending of 
qualitative and quantitative data. The descriptive qualitative portion of the study used 
phenomenology to understand the experiences of the study participants. The descriptive 
quantitative portion of the study used independent and dependent variables to compare frequency 
of participant responses. A mixed mode design is beneficial in theory generating studies (Polit & 
Beck, 2004). The investigators believe their study has the potential to be theory generating.
There are several advantages to implementing a mixed mode design. Polit and Beck 
(2004) state that combining qualitative and quantitative data is a complementary relationship 
using both words and numbers. Implementing both methods can possibly reduce the limitations 
that a single approach could encounter. A mixed mode design is also multidimensional and can 
illustrate not only statistics, but also the experiences and emotions of the participants (Polit & 
Beck).
Setting and Sample
The study was conducted in an outpatient oncology office in a mid-Michigan teaching 
hospital. The study used a nonprobability sampling design. A purposive sampling method was 
used in order to choose subjects who will most represent the topic being researched (Polit & 
Beck, 2004). Subject participation included women ages 18 or older. The inclusion criterion was 
a positive stage I or stage II invasive breast cancer diagnosis prior to the surgical treatment for
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cancer. The exclusion criteria included any invasive breast cancer diagnosis and stage III or stage 
IV breast cancer (Appendix B). The sample for this study was women selected from an oncology 
surgeon’s office after they had been diagnosed with breast cancer, but prior to the surgical 
treatment. This is purposive because all of the potential subjects were diagnosed with breast 
cancer and facing the decision of what type of surgical treatment to undergo. Polit and Beck state 
that this type of sampling does not provide an objective method for “assessing the typicalness” of 
the chosen subjects (p. 294). However, purposive sampling was an effective method to answer 
the research question because all subjects were at the same stage of their cancer treatment as well 
as seeing the same surgeon.
The purposive sampling method was used over an interval from September 2008 through 
January 2009 to draw a sample of 10 participants. There were no refusals from those who met 
the inclusion and exclusion criteria. Of those sampled, 10 women were asked to participate and 
all 10 women agreed with 3 scheduled for MRM surgery and the other seven scheduled for BCS.
Procedure
Written permission to conduct this study was obtained from the Institutional Review 
Board (IRB) of the acute care institution and from the IRB of the University of Michigan 
(Appendix C). The patients of Dr. Raouf Mikhail, oncology surgeon, were asked to be 
participants in the study. Permission from Dr. Mikhail was granted (Appendix D). All women 
who consult Dr. Mikhail regarding breast surgery are given the results of their biopsies from 
their primary care physician. At the initial consult with Dr. Mikhail, they receive the Michigan 
Department of Community Health (2003) booklet, “Breast Cancer: What you need to know 
before treatment” as required by Michigan State law. They are then scheduled for an
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appointment with the Nurse Navigator at Hurley Medical Center. The Nurse Navigator was not 
engaged in this study. The patient's appointment with the Nurse Navigator is to discuss the 
pathophysiology of the type of breast cancer the women have been diagnosed with, available 
surgical treatment options, and education regarding what to expect during and after surgery. The 
Nurse Navigator gave the women a flyer (Appendix E) about the study at this appointment using 
the script (Appendix F) provided by the researchers. After their time with the Nurse Navigator, 
the women were asked if  they would like more information about the study that was in the flyer 
they received. If the woman said yes, the researcher entered the room. It is at this time that the 
subjects were given the "Letter of Introduction" (Appendix G) and asked to participate in this 
study. After questions were answered and the informed consent (Appendix H) was signed, the 
researcher handed out the demographic sheet (Appendix I) and open-ended question (Appendix 
J) to the participant. The participants were asked at this time if they would prefer to write their 
own thoughts and feelings in response to the open-ended question, or to verbally state their 
responses to the researcher while she took notes.
The privacy and confidentiality of each participant was maintained. No identifying 
information was given on the data collected. The participants were consecutively coded with 
numbers and letters to identify surgical choice: 1L, 2L, 3L, 4L, 5L, 6L, 7L, 1M, 2M, 3M. The 
data obtained from these participants was rich in quality and recurrent statements were identified 
to achieve data saturation. The informed consents were kept separate and no names were linked 
to the data collected. Interviews were conducted in a private room with no interruptions.
The researcher ensured constancy of research conditions by being the sole presenter of 
the informed consent, demographic data collection sheet and open ended question sheet to all 
participants. There were no interruptions during the time of data collection. By using one setting,
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all the participants received information from the same physician and Nurse Navigator including 
review of the “green” booklet.
Instruments
The “Factor List” (Appendix A) was specifically developed by Ward, Heidrich and 
Wolberg (1989) to measure the factors that women consider when choosing what type of breast 
cancer surgery they will undergo as treatment. Prior to this 1989 study, a tool to measure these 
concepts was not available. The authors established content validity for the instruments used in 
their study. Content validity is the degree that the items in an instrument represent the content for 
the concepts that are being measured in the study (Polit & Beck, 2004). Content validity for the 
16-item factor-list was assessed by asking an oncology surgeon and nurse specialist to ensure the 
list of items covered all possible factors. The study does not include a content validity index.
Dr. Sandra Ward (personal communication, October, 2007) granted permission to use and 
adapt this 16-item Factor list in this prospective study. Because the original study was 
retrospective, the questionnaire given to the women was written in past tense. The items had to 
be reworded to state the factors as a preoperative reason for choosing the surgery. Also, the 
original study used the Factor list in a questionnaire. In this study, the adapted Factor list served 
as the framework to examine the extent to which prospective (pre-op) content analysis supported 
Ward’s retrospect!ve( post-op) findings. Having more than one study that used the Factor List 
tool increased the reliability of the instrument for retrospective studies (Ward, Heidrich & 
Wolberg, 1989; Mastaglia & Kristjanson, 2001). This study has the potential to extend the 
validity of the Factor List by examining content validity of the factors preoperatively.
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A pen, paper, and the researcher are the instruments used in this study. A demographic 
data sheet (Appendix I) was given to each participant. The data included on the demographic 
survey include age which will be reported as mean. Categorical data such as ethnicity, insurance, 
marital status, education, employment, and family history of breast cancer will be reported as 
percentages. A question regarding the participant’s current satisfaction with her breast 
appearance is the last question on this survey and uses a Likert-type scale. The Likert scale 
ranges from 1 to 5, with 1 meaning highly dissatisfied, 3 meaning neutral, and 5 meaning highly 
satisfied. This variable is ordinal treated as interval and will be expressed using mean and 
standard deviation.
A sheet of paper with one open-ended question was given to each participant (Appendix 
J). The question, “What thoughts and feelings have you experienced since your diagnosis of 
breast cancer that have guided you to your surgical treatment decision?” was read aloud by the 
researcher. Participants were asked by the researcher if they preferred to write their responses or 
verbalize them to the researcher and have her take notes. One participant chose to verbalize her 
responses to the researcher who assumed the expected qualitative researcher role described by 
using the phrase “researcher as instrument” (Polit & Beck, 2004, p. 225). This process was 
helpful to eliminate the problems of different reading and writing capabilities of the participants.
Variables
The dependent variable was the surgical decision that the women chose as treatment for 
breast cancer: Modified Radical Mastectomy (MRM) or Breast Conserving Surgery (BCS). The 
independent variables were the recurring themes determined through content analysis of 
participant responses to the open-ended question. Other independent variables included
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demographic data, such as age, marital status, insurance, employment, and ethnicity, as well as 
family history of breast cancer, current bra size, and current satisfaction of breast appearance.
Data Analysis
Descriptive statistics, percentages, means, and standard deviations were used for the 
demographic variables in this study. Fisher’s Exact was used to examine the relationship 
between actual breast satisfaction and type of surgery. Content analysis was used to analyze the 
narrative data from the open ended question for major categories across subjects. No 
transcribing of data was done because the investigators reviewed the raw data directly.
Content analysis is the process of analyzing the narrative data for recurring themes or 
patterns (Polit & Beck, 2004). The thoughts and feelings that the participants either wrote or 
verbalized to the researcher were analyzed for possible recurring themes. Polit and Beck (2004) 
define a theme as a recurring regularity that becomes apparent during an analysis of qualitative 
data. Ward’s adapted Factor List (Appendix K) was used as a tool to categorize the data. Prior to 
the data analysis, the researchers reviewed the Factor List to develop cue words for each 
numbered factor that would signal the presence of the factor. However, as the Factor List was 
analyzed, it was determined that the cue words were already present in each of the statements. 
Once identified, the adapted Factor List was used as a categorization scheme with corresponding 
codes to organize and sort the data. There were instances when the factor list items were 
insufficient and did not match the raw data that needed to be coded. Each researcher 
independently wrote down the items that did not fit into the adapted Factor List and began 
making additional factors. After all the data were sorted and organized, patterns and themes were 
identified.
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Reliability and Validity
The researchers have used methods to ensure the trustworthiness and credibility of the 
data and analysis. Inter-coder reliability is the degree to which the researchers agree about their 
ratings for the themes and categories when reviewing the participant’s narrative portion of the 
study. The co-investigators independently reviewed each participant’s response, coded the 
findings, and compared findings to assess level of agreement. After the co-investigators agreed 
with ratings of the narrative statements, the thesis Chair reviewed their work. The feedback from 
the Chair supported findings of the co-investigators. The Chair also agreed that the content 
analysis was easily understood. This is called investigator triangulation which reduces the 
possibility of biased interpretation. The content analysis and interpretation can benefit from 
different perspectives (Polit & Beck, 2004).
Researcher credibility also adds to the strength of the study. Diane Welker, RN, MS, 
ANP-BC, the content expert of the study, is a Nurse Practitioner with years of oncological 
experience. She was employed as Nurse Navigator at a breast cancer center and has a great 
amount of experience counseling women with breast cancer throughout their treatment. She was 
also key in the development of the breast cancer center where this study took place. The 
researchers also have years of oncological experience and have counseled and treated many 
women going through breast cancer from diagnosis through treatment. Janet Bamfather, PhD,
RN has competed for and received funding for studies at the local, state and national levels. In 
part, her expertise includes past studies with patients who are hospitalized and have oncology 
problems. Dr. Bamfather has developed an expertise in conducting and teaching clinical nursing 
research related to her lead role in qualitative research data analysis for two funded projects: a
Breast Cancer and Decision Making
State of Michigan project and a National Institutes of Health project. The experience of these 
individuals provided this study with researcher credibility.
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Chapter IV 
Results
Demographic Data
There were a total o f 10 participants in this study. The demographic data (Appendix H) 
were collected and included: marital status, education, insurance, employment, ethnicity, family 
history of breast cancer, type of surgical treatment, age, current bra size and satisfaction with 
current breast appearance. The demographic characteristics of the participants are included in 
Table 1. The mean age for the total population was 59.5 years (S.D. = 15.57). The mean age of 
the 7 participants who chose BCS was 63.3 years (S.D. = 15.77). The mean age of the 3 
participants who chose MRM was 50.7 years (S.D. = 13.32). Most of the sample was Caucasian 
(n=7, 70%) while 30% was African American.
Table 1: Demographic Characteristics of Participants (N = 10)
Number %
Marital Status
Single 1 10
Married 6 60
Divorced 1 10
W idowed 2 20
Education
Less than  High School 
Diploma
1 10
High School G raduate 1 10
Some College 1 10
Associates D egree 4 40
Bachelors D egree 1 10
G rad u a te  D egree 1 10
Other 1 10
Insurance
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Full C overage 9 90
Partial C overage 1 10
Employment
Full Time 5 50
Part Time 2 20
Retired 3 30
Ethnicity
White 7 70
African American 3 30
Family History of Breast 
Cancer
Yes 4 40
No 6 60
Type of Surgical Treatment
Breast Conserving Surgery 
(BCS)
7 70
Modified Radical 
M astectom y (MRM)
3 30
Age
4 0 -4 9 4 40
5 0 -5 9 2 20
6 0 -6 9 2 20
80 - 89 2 20
Bra Size
B 2 20
C 3 30
D 2 20
DD 1 10
DDD 1 10
Unknown 1 10
Breast Satisfaction
1 = Highly Dissatisfied 0 0
2 = Dissatisfied 1 10
3 = Neutral 5 50
4 = Satisfied 2 20
5 = Highly Satisfied 2 20
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Each demographic characteristic was analyzed independently and compared by surgical
treatment choice as illustrated in Tables 2 through 10. Table 2 shows 100% of the MRM group 
were married. The participants in the MRM group all had college degrees, while the BCS group 
ranged from less than high school to a graduate degree (Table 3). All participants had insurance 
coverage. All of the participants in the MRM group (100%, n=3) had full coverage, and 6 out of 
7 in the BCS group had full coverage (Table 4). None of the individuals were unemployed. 
Those currently not working were retired (Table 5). Two participants from each group identified 
a family history of breast cancer (Table 7). One MRM participant did not write an answer for 
current bra size (Table 9). Approximately 43% (n=3) of the BCS participants were either highly 
satisfied or satisfied with their current breast appearance while the MRM participants reported a 
much lower rate (33%, n=l). Fisher’s Exact test revealed no significant relationship between 
demographic variables and actual breast satisfaction (Table 11).
Table 2: Surgical Treatment Decision an d  Marital Status
BCS 
(n = 7]
BCS 
% of n
MRM 
(n = 3)
MRM 
% of n
Single 1 14.29 —
Married 3 42.86 3 100
Divorced 1 14.29 -------- —
W idowed 2 28.57 -------- —
Table 3: Surgical Treatment Decision and  Education
BCS 
fn = 7)
BCS 
% of n
MRM 
(n = 3)
MRM 
% of n
Less than  HS 1 14.29 -------- —
HS Diploma 1 14.29 -------- —
Som e College 1 14.29 -------- —
Associates
D egree
2 28.57 2 66.67
Bachelors — — 1 33.33
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D egree
G rad u a te
D egree
1 14.29 — —
O ther 1 14.29 — —
Table 4: Surgical Treatm ent Decision an d  Insurance
BCS 
(n = 7)
BCS 
% of n
MRM 
(n = 3)
MRM 
% of n
Full C overage 6 84.71 3 100
Partial
C overage
1 14.29 — —
Table 5: Surgical Treatm ent Decision an d  Employment
BCS BCS MRM MRM
(n = 7) % of n (n = 3) % of n
Full Time 4 57.14 1 33.33
Part Time 1 14.29 1 33.33
Retired 2 28.57 1 33.33
Table 6: Surgical Treatm ent Decision and  Ethnicity
BCS 
fn = 7)
BCS 
% of n
MRM 
In = 3)
MRM 
% of n
White 5 71.43 2 66.67
African
Am erican
2 28.57 1 33.33
Table 7: Surgical Treatm ent Decision an d  Family History
BCS BCS MRM MRM
fn = 7) % of n (n = 3) % of n
Yes 2 28.57 2 66.67
No 5 71.43 1 33.33
Table 8: Surgical Treatm ent Decision an d  Age
BCS BCS MRM MRM
(n = 7) % of n (n = 3} % of n
4 0 -4 9 2 28.57 2 66.67
5 0 -5 9 2 28.57 ----- —
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6 0 -6 9 1 14.29 1 33.33
8 0 -8 9 2 28.57 — —
Table 9: Surgical Treatm ent Decision an d  Bra Size
BCS 
(n = 7)
BCS 
% of n
MRM 
(n = 3)
MRM 
% of n
B 1 14.29 1 33.33
C 3 42.86 --- —
D 2 28.57 --- —
DD 1 14.29 --- —
DDD — — 1 33.33
Unknown — — 1 33.33
Table 10: Surgical Treatm ent Decision and  Current Breast Satisfaction
BCS 
(n = 7)
BCS 
% of n
MRM 
(n = 3)
MRM 
% of n
1 Highly 
Dissatisfied
— —
2 Dissatisfied 1 14.29 — —
3 Neutral 3 42.86 2 66.67
4 Satisfied 1 14.29 1 33.33
5 Highly Satisfied 2 28.57 — —
Table 11: Type of Surgery an d  Actual Breast Satisfaction Crosstabulation* (N=10)
Type of Surgery
BCS MRM Total
A
ct
ua
l 
B
re
as
t 
Sa
tis
fa
ct
io
n
Satisfied/Highly Satisfied 3 1 4
Neutral/Dissatisfied 4 2 6
Total 7 3 10
*Fisher’s Exact p  = NS
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Research Question: “What factors influence the surgical treatment decision-making at the time of 
diagnosis for women with breast cancer?”
Themes Identified on the Adapted Factor List
Table 12 presents the participants’ responses as coded using the adapted factor list 
included in Appendix K (Ward, Heidrich, & Wolberg, 1989). The researchers had a 71.43% 
initial agreement rate and had coded 10 out of 14 responses similarly. After discussing the other 
ratings, the researchers collectively agreed upon the remaining 4 ratings. The participants were 
consecutively coded with numbers and letters to identity surgical choice in the order they were 
interviewed: 1L, 2L, 3L, 4L, 5L, 6L, 7L, 1M, 2M, 3M. Of the 12 categories included on the 
factor list, only 5 were identified in the participants’ responses (41.67%). These 5 categories 
include physician’s opinion, other acquaintance with mastectomy experiences, fear of side 
effects from chemo and radiation, length of recovery, and fear of recurrence as influences 
regarding type of surgical treatment chosen.
Physician’s Opinion
The physician’s opinion had the highest occurrence of responses with 9 out of 10 (90%) 
participants stating that this was an impact in surgical treatment choice. All of the MRM 
participants (n=3, 100%) and 85.61% (n=6) of the BCS group stated this as a factor. This theme 
was clearly demonstrated by the following participant responses:
1L) “Dr. Mikhail.. .agreed a lumpectomy would be a good choice for me. Dr. Mikhail
guided me to this step right here because I was really lost as to what to do.”
2L) “Specialist talking. Felt really lucky that had 2 really good specialists”
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3L) “I have great doctors.. .I’m a judge not a doctor.. .1 believe in doing what doctors tell 
you... Dr Mikhail says this is the way to go so this is the way to go.”
5L) “Dr highly recommended for age”
6L) “after discussion, I feel it is the right thing to do”
7L) “the Dr. recommended lumpectomy so I am going with that”
1M) “information from doctor.. .have relied a lot on what docs have said from 
radiologists on”
2M) “physician recommended due to other smaller tumors”
3M) “he said there are four spots in there that are poorly differentiated., .difficult to do 
lumpectomies and get it all out.. .didn’t hesitate when he suggested that”
Fear of Side Effects from Chemo and Radiation
Fear of side effects from chemo and radiation feelings was coded as the second highest 
factor across all participants with a total response rate of 20% including 1 MRM (33.33%) and 1 
BCS (14.29%) participant. This theme refers to the participant’s desire to avoid chemo and 
radiation and is supported by the following participant responses:
7L) “I do not want chemo”
2M) “some fear of upcoming treatments.. .avoid future surgeries (possible chemo 
and radiation).. .praying don’t have to do chemo”
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Other acquaintance with mastectomy experiences, length of recovery and fear of 
recurrence all had a total response rate of 10%. Fear of recurrence and other acquaintance with 
mastectomy experience were both stated by 1 MRM (33.33%) participant and zero BCS 
participants. Conversely, length of recovery was stated by 1 BCS (14.29%) participant and zero 
MRM participants.
Other Acquaintance with Mastectomy Experiences
1M) “friend who had a mastectomy Dr Mikhail did.. .helps that she had someone”
Length of Recovery
4L) “I feel that a lumpectomy is the best decision for me because it is the least 
invasive for me, quicker healing time and all around best fit. I will be able to 
return to my life faster and plan my holidays”
Fear of Recurrence
2M) “hopefully heading off cancer in other breast also”
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New Factors/Themes Identified
There were instances that the factor list items were insufficient and did not match the raw 
data that needed to be coded. Each researcher independently wrote down the items that did not fit 
into the factor list and began making additional factors. The researchers had an 86.21 % initial 
agreement rate and had coded 25 out of 29 responses similarly. After discussing the other 
ratings, the researchers collectively agreed upon the remaining 4 ratings. Collectively comparing 
the items, 10 new categories were developed as presented in Table 13. These categories include 
fear (nonspecified), information given, personal decision, involved support system, strong 
faith/spirituality beliefs, previous experience with someone with breast cancer, guidance from 
the nurse navigator, trust (nonspecified), age, and fear of subsequent surgeries were all identified 
within the participants5 responses to the open-ended question.
Fear (nonspecified)
Of these 10 new categories identified, 60% of the participants stated fear was an 
influence in their surgical treatment decision which included 4 (57.14%) BCS participants and 2 
(66.67%) MRM participants. This fear was not specified, and could not therefore, be placed in 
numbers 7, 9, 10 or 11 on the adapted factor list. These statements were not clear regarding the 
fear that the participants were feeling and were expressed through the following:
1L) “scared55
2L) “scared”
3L) “scared, scared...terrified”
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4L) “I have worked in the medical field for over 25 years, sometimes we know 
too much that it scares us to death and not enough to comfort us”
2M) “anxiety”
3M) “can’t imagine being so tied to breasts I would risk my breast”
Involved Support System
Of the total sample (N=10), 60% of the participants also stated that having an involved 
support system was an important influence in leading the decision for surgical treatment: 4 
(57.14%) were BCS participants and 2 (66.67%) were MRM participants. The support theme 
was demonstrated through direct response statements or participant accompanied by a support 
person. Responses from the participants were:
3L) “my brother is a doctor and he is in agreement.. .wonderful family”
4L) nurse researcher observation of patient accompanied by husband and daughter 
and requested them to stay during data collection
5L) nurse researcher observation of patient accompanied by granddaughter, 
patient relaxed and laughing with granddaughter
6L) nurse researcher observation of patient accompanied by granddaughter
1M) “discussed with family.. .having friend as support to help you listen...” 
observation of close friend with participant during data collection
3M) “I have many years ahead of me with my husband (who is wonderful!)”
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Information Given
Information given was stated by 40% (n=4) of the participants in response to the open- 
ended question as supported by these statements:
2L) “reading information provided.. .1 don’t feel scared asking questions, they 
made me feel very comfortable.. .gave me the info”
4L) “everyone gave me the info to make my decision confidently”
6L) “after discussion, I feel it is the right thing to do”
1M) “information from doctors...I read the green book several times.. .looked on 
internet.. .took upon self [s/c] to find pathology of nodes, called and asked before 
first post op appointment”
Personal Decision/Choice
Across the total sample, all BCS participants (n=3, 30%) responded about their role in 
making a personal decision regarding surgical treatment. This theme is described through 
statements that show women felt their own choice and decision was important in the decision 
making process:
2L) “let me make my decision”
4L) “everyone gave me the info to make decision confidently”
6L) “beautiful to have chance to have caught it in time and have a choice”
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Strong Faith/Spirituality
Within the sample, 30% (n=3) of the participants identified the theme of spirituality or 
faith when discussing factors that impacted their surgical treatment decision. This theme is 
supported with these participants’ responses:
3L) “blessed because God is reminding me I have everything.. .faith in choice”
6L) “I thank my Creator for life.. .much greater profound respect for the care of 
my body and life in general.. .feel it is a little valley I will pass and be fine and 
then get ready to face next obstacle”
nurse researcher observation made that participant was very positive and spiritual 
2M) “praying don’t have to do chemo”
Previous Experience with Someone With Breast Cancer (nonspecified)
This theme was developed due to the participants’ not specifying what surgical treatment 
their acquaintance chose and therefore, could not be placed in the adapted factor list items 3 and 
4. The participants’ responses (n=2, 20%) coded into this new theme were:
5L) while talking to granddaughter participant stated, “Remember Dorothy, didn’t 
have a thing done and she just died”
1M) “friends who have had similar experiences with breast cancer...”
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Fear of Subsequent Surgeries
The majority of the participants (66.67%, n=2) in the MRM group stated that fear of 
more surgery was a factor in their surgical treatment decision. This theme is supported by their 
statements:
1M) “would not want to experience a third surgery if I did not have breast 
removed”
2M) “avoiding future surgeries”
There were three additional factors identified in the narrative responses. These factors 
were only stated one time by one participant. Although not recurring, the researchers felt the 
factors were important because the participants were expressing their personal feelings. One 
factor identified by a participant was trust. She expressed this in stating, “I know Dr. Mikhail and 
Dr. MikhaiFs family, and I know he is a great doctor and I trust him.” A second factor identified 
by a participant was age. She expressed this through the statement, “if I were a younger person, it 
would be a different story.” The third factor identified by one participant was the guidance of the 
Nurse Navigator through the statement, “the Nurse Navigator was very helpful.”
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Chapter V 
Discussion
Theoretical Framework Related to Findings
The results illustrate that this theory-generating study has the potential to expand on the 
Factor List developed by Ward, Heidrich, and Wolberg (1989). Important themes were identified 
from the total sample using the Adapted Factor List. The physician’s opinion had the highest 
occurrence of responses with 90% of the participants stating that this was an impact in surgical 
treatment choice. It was not surprising to see this theme emerge because physicians are the 
experts regarding the available treatment options and take on the responsibility of prescribing 
and providing the treatment to their patient (Halkett et al., 2005). Due to the emotions of denial, 
fear and loss of control during this life changing time, women may desire to take on a more 
dependent role with the physician (Charles, Gafhi, & Whelan, 1999). The factor with the next 
most frequent occurrence (20%) was fear of side effects from chemo and radiation. Length of 
recovery and fear of occurrence were reported at a much lower rate (10%). It seems that the 
Adapted Factor List was best at capturing an important theme, but was less useful in learning 
about the experiences of the participants.
For prospective use, the Adapted Factor List was not a sufficient tool because it did not 
capture all themes identified by the participants. This study does, however, serve as a building 
block for others. Findings support that the Adapted Factor List did not account for 10 identified 
themes in the sample (Table 12). Among these 10 new themes, the two equally high percentages 
(60%) were Fear (nonspecified) and Involved Support System. Halkett et al, (2005) recognize 
support as a factor that can influence the experience of the decision making process regarding
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surgical treatment. When examining and comparing these themes by type of surgery, both 
remained the highest for all identified 10 new themes. In addition, Fear of Subsequent Surgeries 
was equally high at 66.67% for the MRM group only.
Using the qualitative approach allowed women to express their individual thoughts and 
feelings in regard to the decision making process. Conversely, the original Factor List limited the 
women’s responses to the items on the list. There was no area for them to expand on their 
thoughts. This information could have been missed and would be unknown if new themes were 
not identified. There is support that the Adapted Factor List needs to be expanded to include 
more factors as evidenced by the 10 new themes revealed with this study.
Implications o f  the Results
The implications of the results of this study have great potential related to practice, 
research, and policy. Regarding practice, it is the hope of the researchers that the results from 
this study will assist healthcare providers in better understanding the experiences that women go 
through when faced with breast cancer, and to ultimately facilitate the surgical treatment decision 
making process for patients with breast cancer. The investigators know of no other prospective 
study in this area making it a theory-generating study. It is a huge stepping stone for further 
studies to expand and learn more about women’s perspectives during their fight with breast 
cancer. Sharing findings from this study can help gain awareness and support for further needed 
studies in this area. Nurse practitioners have networks that impact policy at state and national 
levels. Health policy can be influenced through setting professional agendas and promoting 
interest groups in organizations such as Michigan Council of Nurse Practitioners and the
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American Academy of Nurse Practitioners. Results will also help to support the evolving role of 
breast cancer centers and breast cancer nurse navigators.
Limitations
The primary limitation of the study was that participants were from one physician and 
one site. The majority of the sample was Caucasian (70%). This homogenous sample limits the 
ability to generalize the findings to various populations. Sample size is another limitation. If the 
sample were larger, results may have been more generalizable for the quantitative portion of the 
study. Although the qualitative data provided rich information., a larger sample size could assist 
in understanding more about the deeper meaning of the participants’ experiences.
Alternative Explanations fo r the Findings
There were areas not considered in this study that could have possibly had an impact on 
the findings. Co-morbidities of the participants were not assessed. As with all cancer patients, the 
treatment decision is influenced by current health status and any other health problems an 
individual has. The amount or type of information that the participant was exposed to regarding 
breast cancer surgery was not included in the data. The women may have also had various 
previous experiences with cancer in their lifetime, either personally or through a family member 
or friend. Family history of breast cancer may have not been accurately depicted. It was 
unknown if there was a “true” family history with a first degree relative (i.e., mother, sister, aunt) 
because this was not specified by the participants. Any of these factors could have affected the 
way the women responded in this study.
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Recommendations for Further Research
Subsequent research in the area of pre-op surgical decision making by women 
with breast cancer is a must. This study, being the first prospective study with this topic known 
to the authors, has great potential for expansion. Further research should consistently include a 
prospective design with larger sample sizes from more than one setting with diverse populations 
and various physicians. Although the relationship between current breast satisfaction and type of 
surgery was not significant in this study, it may be due to the small sample size. Studies should 
focus more on qualitative approaches before quantitative studies are conducted because a major 
benefit is the strong potential to gain knowledge that could otherwise remain unknown. More 
open ended questions would facilitate sharing of thoughts and feelings during this extremely 
emotional and challenging time. It would also be interesting to know more demographic data 
such as the particular occupation the participants have. Perhaps individuals working in the 
healthcare field may have had experiences that affected their decision making process.
Although this study does provide insight into the breast cancer decision making 
experience, clinicians must be cautioned that the findings need to be replicated in subsequent 
prospective studies before making major decisions based on these findings alone. Replication of 
this study should include a more diverse clinical setting to gain a deeper insight to the breast 
cancer experience among a more diverse population.
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Appendix A
The Factor List (Ward, Heidrich, & Wolberg, 1989).
1. Fear of recurrence
2 . Avoiding a second surgery
3. Physician’s preference
4. Fear of dying from cancer
5. Side effects of radiotherapy
6 . Others MRM experiences
7. Others BC experiences
8 . Another’s preference
9. Fear of radiotherapy
10 . Arm mobility or strength
11 . Same survival rate for both
12. Losing a breast
13. Inconvenience of radiotherapy
14. Partner’s feelings
15. Breast reconstruction
16. Amount of pain involved
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Appendix B 
The Stages of Breast Cancer
Inclusion Criterion
Stage I The tumor is between 0-2cm in size. The lymph nodes are negative for presence 
of cancer and there is no evidence of metastasis.
Stage II The tumor is small (2-5 cm) with 1-3 positive lymph nodes or large (greater than 
5cm) with negative lymph nodes.
Exclusion Criterion
Stage III The tumor size can vary from undetectable to greater than 5 cm with more than 4 
positive lymph nodes under the arm or chest wall. No distant metastasis.
Stage IV The tumor can be any size with any number of positive lymph nodes. Distant 
metastasis present.
(National Comprehensive Cancer Network, 2009).
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Appendix C 
University of Michigan IRB Approval Letter
To: Dr. Janet Barnfather
From: M arianne McGrath
Cc:
Ja n e t Barnfather
D eborah Dimond
Elizabeth Holifield
Diane Welker
Subject: Initial Study Approval for [HUM00013599]
SUBMISSION INFORMATION:
Study Title: Dimond/Holifield: Breast Cancer and Factors Influencing the Decision-Making Process 
Full Study Title (if applicable):
Study eResearch ID: HUM00013599 
D ate of this Notification from IRB:3 /3 /2008  
Initial IRB Approval Date: 2 /23 /2008
Current IRB Approval P eriod :2 / 2 3 /2 0 0 8  - 2 / 2 2 /2 0 0 9  
Expiration Date: Approval for this expires a t 11 :5 9  p.m . on 2 /2 2 /2 0 0 9
UM Federalwide Assurance (FWA): FWA00004969 expiring on 5/10/2009 
OHRP IRB Registration N um ber(s): IRB00000248
NOTICE OF IRB APPROVAL AND CONDITIONS:
The IRB Flint has reviewed and approved the  study referenced above. The IRB determ ined th a t the  
proposed research conforms with applicable guidelines, S ta te  and federal regulations, and the 
University of Michigan's Federalwide Assurance (FWA) with the  D epartm ent of Health and Human 
Services (HHS). You m ust conduct this study in accordance with the description and information 
provided in the  approved application and associated docum ents.
APPROVAL PERIOD AND EXPIRATION:
The approval period for this study is listed above. Please note the expiration date. If the  approval 
lapses, you m ay not conduct work on this study until appropriate approval has been re-established, 
excep t as  necessary  to  elim inate apparen t im m ediate hazards to  research subjects. Should the  latter 
occur, you m ust notify the  IRB Office as soon as possible.
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IMPORTANT REMINDERS AND ADDITIONAL INFORMATION FOR INVESTIGATORS 
APPROVED STUDY DOCUMENTS:
You m ust use any date-stam ped  versions of recruitm ent m aterials and informed consent docum ents 
available in the  eResearch workspace (referenced above). D ate-stam ped m aterials are available in the 
"Currently Approved Docum ents" section on the  "Docum ents" tab.
RENEWAL/TERMINATION:
At least two m onths prior to  th e  expiration da te , you should subm it a continuing review application 
e ither to renew or term inate  the  study. Failure to allow sufficient tim e for IRB review may result in a 
lapse of approval th a t may also affect any funding associated with the study.
AMENDMENTS:
All proposed changes to  the  study (e .g ., personnel, procedures, or docum ents), m ust be approved in 
advance by the  IRB through the  am endm ent process, except as necessary to eliminate apparent 
im m ediate hazards to  research subjects. Should the  latter occur, you m ust notify the  IRB Office as 
soon as possible.
AEs/O RIO s:
You m ust inform th e  IRB of all unanticipated events, adverse events (AEs), and other reportable 
information and occurrences (ORIOs). These include but are not limited to events and/or information 
th a t may have physical, psychological, social, legal, or economic impact on the research subjects or 
other.
Investigators and research staff are  responsible for reporting information concerning the  approved 
research to the  IRB in a timely fashion, understanding and adhering to the reporting guidance 
(h ttp ://w w w .m ed.um ich .edu/irbm ed/ae orio/index.htm  ), and not implementing any changes to the  
research without IRB approval of the  change via an am endm ent submission. When changes are 
necessary  to  elim inate apparen t im m ediate hazards to the  subject, implement the  change and report 
via an ORIO an d /o r am endm ent submission within 7 days after the  action is taken. This includes all 
information with the  potential to impact the  risk or benefit assessm ents of the  research.
SUBMITTING VIA eRESEARCH:
You can access the  online forms for continuing review, am endm ents, and AEs/ORIOs in the  eResearch 
workspace for this approved study (referenced above).
MORE INFORMATION:
You can find additional information about UM's Human Research Protection Program (HRPP) in the  
O perations Manual and o ther docum ents available at: w w w .research.um ich.edu/hrppp.
J
M arianne McGrath
Chair, IRB Flint
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Approval Documentation
To V (horn it May Concern:
I, Dr. Mikhail, have read the background information, literature review, and planned methodology for the study. 
"What factors influence the surgical treatment decision-making for women with breast cancer?" I approve of this 
stud; r and agree with the planned methodology and grant permission to Deborah Dimond and Elizabeth Holrfield, 
both graduate students at the University of Michigan-Flint, to conduct this study with my breast cancer patients at 
Hurley Medical Center.
S i n c e r e l y ,
107
Dr. R 
G- 
Flint, 
(810)
aouf Mikhail
5 North Ballenger Highway 
Ml 48503 
238-1118
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Appendix E 
Breast Cancer Decision Making Study Flyer 
The diagnosis o f  breast cancer is a life changing event.
Be part o f  an informative breast cancer research study:
• Have you been diagnosed with Stage I or II breast cancer and are in the process of 
deciding upon the type of surgical treatment you will have?
•  Would you be willing to share your experience and perspectives about the decision for 
surgical treatment for your breast cancer?
If you answered YES to these questions, you are eligible to participate in an informative breast 
cancer research study.
The purpose of this research study is to assess the woman’s perspective and what factors affect 
her decision making process for breast cancer surgical treatment. The information gathered in 
this study will be beneficial to healthcare providers to better understand this difficult and 
emotional decision for woman with breast cancer. Participation will receive a $20 gas card.
The study is being conducted with Dr. Raouf Mikhail’s patients at Hurley Medical Center.
Please call Deborah Dimond, RN BSN and Graduate Nurse Practitioner Student at the University 
of Michigan-Flint Nursing Department at (810)730-6235 or Elizabeth Holifield, RN BSN and 
Graduate Student at the University of Michigan-Flint at (810)624-1592 for more information.
You will be asked if you would like more information regarding this study at your next 
appointment at Hurley Medical Center. If you decide you would like further information, 
Deborah Dimond or Elizabeth Holifield will be available to answer any questions you may have. 
If you decide you would not like further information, your care will not be affected in any way.
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Appendix F 
Oral Script
Nurse Navigator Visit With Patient
“Two University of Michigan-Flint graduate students are conducting a research study at Hurley 
with Dr. Mikhail’s breast cancer patients. I am including a flyer in your packet for your review. I 
cannot answer any questions about the study, but if you are interested after reading the flyer, 
there will be an opportunity to speak with one of the students today.”
Nurse Navigator Visit With Patient After Time Given to Read
“Did you have an opportunity to read the flyer regarding the research study conducted by the two 
University of Michigan-Flint graduate students?”
If the patient says “yes”, reply:
“Would you be interested in meeting with Deborah or Elizabeth for more information? They are 
here and can answer any questions you may have.”
If the patient says “no”, reply:
“Here is the flyer describing the study. If you are interested, you can meet with one of the 
students for information about the study. They are here and can answer any questions you may 
have.”
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Appendix G 
Letter of Introduction to Participant
Dear Patient,
Deborah Dimond, RN, BSN and Elizabeth Holifield, RN, BSN, both enrolled in the research 
courses of the Nurse Practitioner program at the University of Michigan Flint, are conducting a 
research study titled, “What factors affect the surgical treatment decision-making process for 
women with breast cancer?” at Dr. Raouf Mikhail’s office from May 2008 through August 2008. 
Any patient who has signed the informed consent will be able to participate. Participation is 
completely voluntary and will not affect care provided in any way.
If you would like more information, please contact Deborah Dimond and Elizabeth Holifield 
who would be glad to speak with you about the research study. Contact information provided 
below.
Sincerely,
Deborah L. Dimond, RN, BSN, U of M- Flint Student
dholden@ umflint.edu 
(810) 730-6235
Elizabeth Holifield, RN, BSN, U of M- Flint Student
adamholifield@ bellsouth.net
(810) 624-1592
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Appendix H 
Informed Consent
TITLE: Factors that Affect the Surgical Decision-Making Process among Women 
with Breast Cancer 
PRINCIPAL INVESTIGATORS:
Deborah Dimond, RN BSN
Dimond4ever@ sbcglobal.net
(810)730-6235
Elizabeth Holifield, RN BSN
adamholifield@ bellsouth.net
(810)624-1592
Why is my consent being requested?
Deborah Dimond, RN, BSN and Elizabeth Holifield, RN, BSN, both enrolled in the research 
courses in the Nurse Practitioner program at the University of Michigan-Flint will conduct a 
research study titled: Factors that affect the surgical treatment decision-making process among 
women with breast cancer. The study will take place at Hurley Medical Center from February 
2008 through June 2008.
What is the purpose o f the study?
This study will investigate what factors are important to women with breast cancer and whether 
these factors have an influence on the surgical decision for breast cancer treatment. This study 
will be beneficial for health c a re  providers to understand the experience that you are  
going through, and may ultimately facilitate the surgical treatment decision making process for 
patients with breast cancer.
What will my involvement in this study entail?
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At your second scheduled appointment following your initial meeting at Hurley Medical Center, 
you will be asked to write down or verbalize any personal thoughts you have had since your 
diagnosis of breast cancer that have brought you to your decision about the type of surgical 
treatment you will have. You can write your own thoughts and feelings or share them with the 
researcher who will write them for you. Your written permission is required before you can 
participate in the study. In addition to providing your thoughts and feelings to the above 
question, those who choose to participate will also be asked to complete a demographic data 
sheet. Participation in this study will take approximately 15 minutes of your time. You will only 
be asked to complete the demographic data sheet and write or verbalize your thoughts and 
feelings at this one point in time. No follow up or contact is necessary unless there are questions 
you wish to discuss.
What are the risks involved with this study?
There are no foreseeable risks to participate in this study unless you feel it will increase your 
stress at this emotional time. Deborah or Elizabeth will spend as much time as you may need to 
discuss your concerns or uncomfortable feeling. Deborah and Elizabeth can also provide 
appropriate referrals to professional resources as needed. Your participation in this study is 
completely voluntary.
What are the benefits o f this study?
Although you may not receive direct benefit from your participation, others may ultimately 
benefit from the knowledge obtained in this study. There are no costs to you resulting from your 
participation in the study. Participants in this study will receive a $20 gas card after signing the 
informed consent to thank you for your time.
Will my information given be kept unidentified?
You will not be identified in any reports on this study. Records will be kept confidential to the 
extent provided by federal, state, and local law. However, the Institutional Review Board and 
university responsible for monitoring this study may inspect these records. Following analysis of 
all data, the demographic data sheet and all other information you provided will be destroyed.
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If you agree to take part in this research study, please sign and date this form and bring it to your 
follow-up appointment at Hurley Medical Center. If you have any questions, please call the 
researchers, Deborah Dimond (810)730-6235 or Elizabeth Holifield (810)624-1592. Further 
questions can also be directed to Dr. Janet Barnfather, chairperson of the study, at (810)742- 
3420, or Diane Welker, content expert of the study, at (810) 257-7346. Should you have 
questions regarding your rights as a research participant, please contact the Institutional Review 
Board, Sally Conley, 530 French Hall, 303 E. Kearsley Street, Flint, MI 48502-1950, (810) 762- 
3383 phone, siconley@umflint.edu. The Hurley Medical Center Institutional Review Board 
(810) 257-9974 can also answer any questions you may have regarding your rights as a research 
participant.
VOLUNTARY CONSENT
Your participation in this project is voluntary. Even after you sign the informed consent 
document, you may decide to leave the study at any time without penalty or loss of benefits to 
which you may otherwise be entitled. Your care and treatment will not be affected by your 
participation in this study in any way. One copy of this document will be kept together with the 
research records of this study. Also, you will be given one copy to keep.
All of the above has been explained to me and I have been given the opportunity to ask questions 
and have those questions answered. I understand that, throughout my participation in this 
research study, I am encouraged to ask any additional questions I may have. Deborah Dimond 
and Elizabeth Holifield will answer any further questions I may have concerning the study. I 
hereby consent to participate in the study.
Patient Signature Date
Witness Signature Date
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Demographic Data Sheet
Check all that Apply
1. Marital Status:
Single  Married  Divorced  Separated  Widowed
Single, Living with Another____
2. Education:
Less than High School Diploma  High School Graduate  Some CoIlege_
Associates Degree  Bachelors Degree  Graduate Degree  Other___
3. Insurance:
Full Coverage  Partial Coverage None____
4. Employment:
Full Time  Part Time  Unemployed  Retired  Other____
5. Ethnicity:
White  African American  Hispanic  Indian  Asian____
Other____
6 . Family History of Breast Cancer:
Yes  No____
7. Type of Surgical Treatment you are undergoing for Breast Cancer:
Mastectomy______  Lumpectomy_____
Your Age:______
Current Bra Size:_________
Rate the following question from 1-5, 5 = highly satisfied, 3 = neutral, 1 = highly dissatisfied 
Satisfaction with Current Breast Appearance: 1 2 3 4 6
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Appendix J 
Open-Ended Question
Please read the question below and write down any thoughts or feelings. There are no right or 
wrong answers. This is an opportunity to share how you are feeling. Phrases or single words may 
be used to describe your feelings to this question:
“What thoughts and feelings have you experienced since your diagnosis of breast cancer 
that have guided you to your surgical treatment decision?”
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Appendix K
Adapted Factor List (Ward, Heidrich, Wolberg, 1989)
Factor Present in Narrative
Knowing the  survival Rate is equal for 
m astectom y a n d  breast conserving 
surgery will im pact my surgical decision.
The physician’s opinion will im pact my 
surgical decision.
O ther a cq u a in tan ces  with m astectom y 
experiences will im pact my surgical 
decision.
O ther acq u a in tan ces  with breast 
conserving experiences will im pact my 
surgical decision.
My partner's feelings will im pact my 
surgical decision.
Concerns related  to arm mobility an d  
strength will im pact my surgical decision.
Fear of side effects from radiation and  
chem otherapy  will im pact my surgical 
decision.
Length of recovery following surgery will 
im pact my surgical decision.
Fear of losing a  breast will im pact my 
surgical decision.
Fear of recurrence will im pact my 
surgical decision.
Fear of dying from c a n c e r  will im pact my 
surgical decision.
Satisfaction of current breast 
a p p e a ra n c e  will im pact my surgical 
decision.
